Zelluna Immunotherapy

Developer of TCR-based therapies for a wide range of cancer types

placeOslo, Oslo, Norway calendar_todayFounded 2016 groups18 employees language zelluna.com

Registered entities

Social engagement

Social engagement: 7.2K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital240%
Other / undisclosed360%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

1 Jun 2026 · Junior scientist

Based on job postings tracked across public sources.

Recent activity

25 May 2026
Event
Global Forum
15 May 2026
Event
7th Annual TCR-Based Therapies Summit
11 May 2026
Event
ASGCT 2026
Coming soon